Join
Live feed
·
INSIDERFilingvia Quantisnow
MiNK Therapeutics Inc. logo

Director Holcomb John Bradley was granted 2,330 shares, increasing direct ownership by 207% to 3,458 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
INKT· MiNK Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INKT (MiNK Therapeutics Inc.) and more on Quantisnow.